Review thousands of videos, slides, abstracts and reports from previous ESC Congresses
online, anytime, without subscription
Scientifically-vetted articles summarising key findings presented at congresses organised by the ESC
2017 editions now available
Top advances and key clinical trials contained in this report include:
The feature article provides an overview of the new ESC Clinical Practice Guidelines released during the Congress, covering the management of AMI in patients who present with STEMI, the diagnosis and treatment of PADs, the management of valvular heart disease, and a focused update on dual antiplatelet therapy in patients with CAD.
Also included are articles that contain information on selected areas of cardiovascular medicine including cholesterol lowering therapy for primary and secondary prevention, a look at future therapies for heart failure, and the prevention and management of acute stroke.
Read the full report here
This publication is supported by SERVIER
The feature article takes a closer look at current and evolving treatments for AF including a hybrid ablation approach that combines the strengths and minimises the limitations of either surgical or catheter ablation alone, pulmonary vein isolation, and antiarrhythmic drug therapy.
The issue also contains articles that reflect on four decades of ICD therapy and indications for 2017, as well as the use of anticoagulant therapy for cardioversion of AF.
This publication is supported by Boehringer Ingelheim
The feature article reviews the newly released 2017 ESC Clinical Practice Guidelines for the Management of AMI in Patients Presenting with STEMI; highlighting changes from the 2012 guidelines.
The issue also contains articles that discuss the use of pharmacotherapy after STEMI and the use of P2Y12 inhibitors for the treatment of patients with ACS.
This publication is supported by Bayer AG
The feature article concentrates on the newly released 2017 ESC Clinical Practice Guidelines on the Diagnosis and Treatment of PADs. Changes from the 2011 guidelines include the use of a “vascular team” for multidisciplinary management, risk stratification for asymptomatic carotid disease, and a focus on lower extremity disease.
The issue also contains articles explore the 2017 ESC Clinical Practice Guidelines focused update on dual antiplatelet therapy, and the management of PAD patients who also have concomitant cardiac diseases, including CAD, atrial fibrillation, and heart failure.
The top advances and key clinical trials contained in these reports include:
The featured article provides a topline summary of the 4 new ESC Clinical Practice Guidelines on atrial fibrillation, cardiovascular disease prevention, dyslipidemia, and heart failure.
Also included are articles on new drugs being developed for the treatment of heart failure and the reversal of the effects of non-vitamin K oral anticoagulants.
ESC Congress 2016 in Review is supported by SERVIER in the form of an unrestricted educational grant.
The featured article is dedicated to the 2016 ESC Clinical Practice Guidelines on Atrial Fibrillation (AF).
You will also find information on reducing the burden of AF through prevention and treatment, updates on treating AF in a complex environment, and the use of miniature leadless pacing systems.
ESC Congress 2016 in Review - Focus on Arrhythmias is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.
ESC Congress 2015 in Review is supported by SERVIER in the form of an unrestricted educational grant.
Read the full report here
ESC Congress in Review - Focus on Prevention is supported by Amgen
Read the full report hereView the table of contents here
EHRA EUROPACE-CARDIOSTIM 2015 in Review is supported by Daiichi Sankyo Europe GmbH in the form of an unrestricted educational grant.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved